Expectations trend
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsNASDAQConsumer StaplesAgricultural Farm ProductsSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for SDOT yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
complete integration of Anira Consulting FZC | Sadot Group finished buying Anira Consulting in June 2026. | Intact | failure to integrate Anira Consulting by end of FY26 | Qualitative condition This condition has no defined numerical measure. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Oct 6–Nov 4 · 0 recorded
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a speculative turnaround with high risk, not a proven compounder. The thesis is still in a watch state, and confidence has fallen from medium to low as recent performance remains weak.
The valuation evidence points to SDOT as cheap versus peers, but model confidence is low and the snapshot does not provide enough detail to judge the market’s exact expectations. Low fragility does not remove the company-specific risks tied to recurring losses, obligations, and listing compliance.
In the near term, erratic earnings and smaller-company risk leave a high chance of an earnings miss. Losses narrowed by 2026-Q2, and TradeOS recorded preliminary gross revenue from its first commercial transactions in July, but adoption is still early. Management is also working to strengthen the balance sheet and maintain Nasdaq compliance, with progress still conditional.
Over the next few quarters, the thesis depends on wider TradeOS adoption, continued improvement in operating results, and evidence that the company can address its obligations and maintain listing compliance. The sector backdrop could help if bellwethers continue to report strong results, while weakening employment or poorer sector results could add pressure.
Over a 1-to-3-year horizon, SDOT’s long-term thesis rests on a successful turnaround, but execution and financial risks remain high and the evidence is limited. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| Analysts expect earnings per share of $14.40 in 2026, up from a loss last year. |
| Intact |
| EPS falls below $14.40 in FY26 |
Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
resolve Nasdaq listing compliance issues | A supporting condition in SADOT GROUP INC's published investment case. The stated target is compliance with Nasdaq listing rules. | Intact | Nasdaq delisting or failure to meet listing standards | Qualitative condition This condition has no defined numerical measure. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
operating income improves from negative $2.53M in 2026-Q1 | A primary condition in SADOT GROUP INC's published investment case. The stated target is operating income > -2.53 million USD. | Broken | operating income falls below -2.53 million USD in 2026-Q1 | Operating income: $-800,000 FY2026-Q2; GAAP. Published target: operating income > -2.53 million USD. The stored target says 2026-Q1; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Aug 14, 2026-800,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Nov 18, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.